Preclinical evaluation of pharmacokinetics and safety of melatonin in propylene glycol for intravenous administration
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
Melatonin is a highly effective treatment in different animal models of excitotoxicity or ischemia/reperfusion injury. Due to a lack of patentability, commercial sponsors are not interested in funding clinical evaluations of melatonin. Investigators may initiate small‐scale clinical evaluation, and intravenous (i.v.) administration is appropriate in acute stroke patients. Institutional Review Boards may require proper preclinical evaluation of the preparation. In this pharmacokinetic and safety study, melatonin in propylene glycol was evaluated in adult male Sprague–Dawley rats. Following a single i.v. injection at 5 or 15 mg/kg, plasma concentrations of melatonin increased to 39 and 199 million pg/mL at 2 min and 128 000 and 772 000 pg/mL at 120 min. Within 60 min of injection, the blood pressure, heart rate and body temperature remained unaffected. Melatonin at 5 mg/kg did not influence the complete blood counts at 60 min, but melatonin at 15 mg/kg had some effects on the differential white cell and platelet counts. Melatonin at 5 or 15 mg/kg slightly elevated some liver enzymes at 60 min of injection, and melatonin at higher dose also elevated plasma creatinine and lactate dehydrogenase levels. At 24 hr after completion of six daily injections of melatonin, there was a 5.5% reduction in body weight. Gross postmortem examination and histological examination of the brain, kidney, liver and spleen did not reveal any evidence of toxicity. In conclusion, melatonin in propylene glycol markedly elevates plasma levels of melatonin with no serious toxicity. This preparation should be further evaluated in human patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
NXY-059 for Acute Ischemic Stroke
Lees, K. R., Zivin, J. A., Ashwood, T., Davalos, A., Davis, S. M., Diener, H.-C., Grotta, J., Lyden, P., Shuaib, A., Hårdemark, H.-G., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052980 · Cited by 660
Cited by
Melatonin and Reproduction Revisited
Reiter, R. J., Tan, D.-X., Manchester, L. C., Paredes, S. D., Mayo, J. C., & Sainz, R. M. (2009) · Biology of Reproduction · doi:10.1095/biolreprod.108.075655 · Cited by 421
Antiinflammatory Activity of Melatonin in Central Nervous System
Esposito, E., & Cuzzocrea, S. (2010) · Current Neuropharmacology · doi:10.2174/157015910792246155 · Cited by 407
Tarocco, A., Caroccia, N., Morciano, G., Wieckowski, M. R., Ancora, G., Garani, G., & Pinton, P. (2019) · Cell Death & Disease · doi:10.1038/s41419-019-1556-7 · Cited by 299
Peyrot, F., & Ducrocq, C. (2008) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2008.00580.x · Cited by 291
Melatonin augments hypothermic neuroprotection in a perinatal asphyxia model
Robertson, N. J., Faulkner, S., Fleiss, B., Bainbridge, A., Andorka, C., Price, D., Powell, E., Lecky-Thompson, L., Thei, L., Chandrasekaran, M., et al. (2013) · Brain · doi:10.1093/brain/aws285 · Cited by 254
Metadata
- Authors
- Cheung, R. T. F., Tipoe, G. L., Tam, S., Ma, E. S. K., Zou, L. Y., & Chan, P. S.
- Venue
- Journal of Pineal Research
- Publisher
- Wiley
- Published
- 2006-08-21
- Volume
- 41
- Issue
- 4
- Pages
- 337-343
- ISSN
- 0742-3098 (ISSN-L)
- 1600-079X
- OpenAlex
- W2053923319
- Cited by
- 59
- References
- 1
- FWCI
- 1.84
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Preclinical evaluation of pharmacokinetics and safety of melatonin in propylene glycol for intravenous administration. https://app.cochat.ai/papers/10.1111/j.1600-079x.2006.00372.x
- The paper
- Cheung, R. T. F., Tipoe, G. L., Tam, S., Ma, E. S. K., Zou, L. Y., & Chan, P. S. (2006). Preclinical evaluation of pharmacokinetics and safety of melatonin in propylene glycol for intravenous administration. Journal of Pineal Research. https://doi.org/10.1111/j.1600-079x.2006.00372.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.